PFIZER
Back to Income Statement
|
PFIZER Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,281 Cr | ₹2,193 Cr | ₹2,425 Cr | ₹2,611 Cr | ₹2,239 Cr |
What is the latest Revenue of PFIZER ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,281 Cr |
| Mar2024 | ₹2,193 Cr |
| Mar2023 | ₹2,425 Cr |
| Mar2022 | ₹2,611 Cr |
| Mar2021 | ₹2,239 Cr |
How is Revenue of PFIZER Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,281 Cr | 4.02 | |
| Mar2024 | ₹2,193 Cr | -9.55 | |
| Mar2023 | ₹2,425 Cr | -7.13 | |
| Mar2022 | ₹2,611 Cr | 16.64 | |
| Mar2021 | ₹2,239 Cr | - | |
Compare Revenue of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹20,896.6 Cr | 2.6% | -3.3% | -21.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 2.6% |
-3.3% |
-21.7% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses